These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9694432)
21. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system. Winblad B; Messamore E; O'Neill C; Cowburn R Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837 [TBL] [Abstract][Full Text] [Related]
22. Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models. Toledano A; Alvarez MI Curr Alzheimer Res; 2004 Aug; 1(3):189-214. PubMed ID: 15975067 [TBL] [Abstract][Full Text] [Related]
23. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Mufson EJ; Cochran E; Benzing W; Kordower JH Dementia; 1993; 4(5):237-50. PubMed ID: 7505157 [TBL] [Abstract][Full Text] [Related]
24. The cholinergic system in Alzheimer's disease. Kása P; Rakonczay Z; Gulya K Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159 [TBL] [Abstract][Full Text] [Related]
25. [The EEG as an indicator of cholinergic deficit in Alzheimer's disease]. Adler G Fortschr Neurol Psychiatr; 2000 Aug; 68(8):352-6. PubMed ID: 11006862 [TBL] [Abstract][Full Text] [Related]
26. Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. Moghadam FH; Alaie H; Karbalaie K; Tanhaei S; Nasr Esfahani MH; Baharvand H Differentiation; 2009; 78(2-3):59-68. PubMed ID: 19616885 [TBL] [Abstract][Full Text] [Related]
27. Attempts to make models for Alzheimer's disease. Shiosaka S Neurosci Res; 1992 May; 13(4):237-55. PubMed ID: 1321388 [TBL] [Abstract][Full Text] [Related]
29. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Mesulam M Learn Mem; 2004; 11(1):43-9. PubMed ID: 14747516 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease. Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551 [TBL] [Abstract][Full Text] [Related]
31. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Weis C; Marksteiner J; Humpel C Neuroscience; 2001; 102(1):129-38. PubMed ID: 11226676 [TBL] [Abstract][Full Text] [Related]
32. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Whitehouse PJ; Price DL; Struble RG; Clark AW; Coyle JT; Delon MR Science; 1982 Mar; 215(4537):1237-9. PubMed ID: 7058341 [TBL] [Abstract][Full Text] [Related]
33. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Arendt T; Bigl V; Arendt A; Tennstedt A Acta Neuropathol; 1983; 61(2):101-8. PubMed ID: 6637393 [TBL] [Abstract][Full Text] [Related]
34. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. Chan-Palay V J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283 [TBL] [Abstract][Full Text] [Related]
35. Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basal forebrain. Hodges H; Allen Y; Kershaw T; Lantos PL; Gray JA; Sinden J Neuroscience; 1991; 45(3):587-607. PubMed ID: 1775235 [TBL] [Abstract][Full Text] [Related]
36. Recent progress in the research of Alzheimer's disease. Riekkinen PJ; Laulumaa V; Sirviö J; Soininen H; Helkala EL Med Biol; 1987; 65(2-3):83-8. PubMed ID: 3309490 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of Alzheimer's disease]. López OL; Becker JT Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384 [TBL] [Abstract][Full Text] [Related]
38. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352 [TBL] [Abstract][Full Text] [Related]